These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32790768)

  • 21. Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
    Alvarez Cubero MJ; Lorente JA; Robles-Fernandez I; Rodriguez-Martinez A; Puche JL; Serrano MJ
    Methods Mol Biol; 2017; 1634():283-303. PubMed ID: 28819860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.
    Kanayama M; Kuwata T; Mori M; Nemoto Y; Nishizawa N; Oyama R; Matsumiya H; Taira A; Shinohara S; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Tanaka F
    Cancer Sci; 2022 Mar; 113(3):1028-1037. PubMed ID: 34964211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
    Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
    Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.
    Vismara M; Reduzzi C; Silvestri M; Murianni F; Lo Russo G; Fortunato O; Motta R; Lanzoni D; Giovinazzo F; Miodini P; Pasquali S; Suatoni P; Pastorino U; Roz L; Sozzi G; Cappelletti V; Bertolini G
    Clin Chem; 2022 May; 68(5):691-701. PubMed ID: 35304611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer.
    Li C; Yang S; Li R; Gong S; Huang M; Sun Y; Xiong G; Wu D; Ji M; Chen Y; Gao C; Yu Y
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7646-7658. PubMed ID: 35104098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma.
    Yoneda K; Kuwata T; Chikaishi Y; Mori M; Kanayama M; Takenaka M; Oka S; Hirai A; Imanishi N; Kuroda K; Ichiki Y; Ohnaga T; Tanaka F
    Cancer Sci; 2019 Feb; 110(2):726-733. PubMed ID: 30499156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges in the enumeration and phenotyping of CTC.
    Coumans FA; Ligthart ST; Uhr JW; Terstappen LW
    Clin Cancer Res; 2012 Oct; 18(20):5711-8. PubMed ID: 23014524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
    Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
    Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model.
    Muhanna N; Mepham A; Mohamadi RM; Chan H; Khan T; Akens M; Besant JD; Irish J; Kelley SO
    Nanomedicine; 2015 Oct; 11(7):1613-20. PubMed ID: 25981337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EpCAM-based Flow Cytometric Detection of Circulating Tumor Cells in Gallbladder Carcinoma Cases.
    Awasthi NP; Kumari S; Neyaz A; Gupta S; Agarwal A; Singhal A; Husain N
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3429-3437. PubMed ID: 29286615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
    Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
    BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ClearCell® FX, a label-free microfluidics technology for enrichment of viable circulating tumor cells.
    Lee Y; Guan G; Bhagat AA
    Cytometry A; 2018 Dec; 93(12):1251-1254. PubMed ID: 30080307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.
    Chalfin HJ; Kates M; van der Toom EE; Glavaris S; Verdone JE; Hahn NM; Pienta KJ; Bivalacqua TJ; Gorin MA
    Urology; 2018 May; 115():82-86. PubMed ID: 29432873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
    Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
    J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of non-EpCAM based circulating tumor cell assays.
    Austin RG; Huang TJ; Wu M; Armstrong AJ; Zhang T
    Adv Drug Deliv Rev; 2018 Feb; 125():132-142. PubMed ID: 29366804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.